Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, 07 1995, 1538-1541, Vol 39, No. 7
T Kuchta, C Leka, P Farkas, H Bujdakova, E Belajova and NJ Russell
The effects of 6-amino-2-n-pentylthiobenzothiazole (APB), a new antifungal
agent, on ergosterol biosynthesis in Candida albicans and Saccharomyces
cerevisiae were studied, using [14C]acetate incorporation. In C. albicans,
the inhibition of growth was accompanied by a marked inhibition of acetate
incorporation in 4-desmethylsterols, with a significant portion of the
radiolabel being incorporated in 4,4- dimethylsterols, lanosterol, and
4,4-dimethylzymosterol and minor amounts being incorporated in
4-methylsterols and squalene. The data are interpreted as evidence of a
block of the ergosterol biosynthesis pathway at the level of
4-demethylation of 4,4-dimethylzymosterol, with partial inhibition of
lanosterol 14-dimethylation and squalene epoxidation also being possible.
In 6-amino-2-n-pentylthiobenzothiazole- treated S. cerevisiae, a
significant amount of the radiolabel was incorporated also in
4-methylsterols, 4-methylzymosterol, and 4- methylfecosterol, indicating
that in this microorganism there are different sensitivities of the two
4-demethylations and that the pathway is blocked at the level of
4-demethylation of 4-methylsterols.
Copyright © 1995 by the American Society for Microbiology. All rights reserved.
Inhibition of sterol 4-demethylation in Candida albicans by 6-amino-2-n- pentylthiobenzothiazole, a novel mechanism of action for an antifungal agent
Food Research Institute, Bratislava, Slovakia.
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»